NCT02612116View on ClinicalTrials.gov

Comparison of Administration Strategies of Ticagrelor in Patients With Unstable Angina Pectoris, a Pharmacokinetic / Pharmacodynamic Study

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

September 30, 2016

Conditions

Unstable Angina Pectoris

Interventions

DRUG

Pulverized ticagrelor sublingually

Pulverized ticagrelor (180 mg) administered sublingually

DRUG

Pulverized ticagrelor orally

Pulverized ticagrelor (180 mg) administered orally

DRUG

Integral ticagrelor

Integral ticagrelor (180 mg) administered orally

Trial Locations (1)

85-094

Cardiology Department, Dr. A. Jurasz University Hospital, Bydgoszcz

All Listed Sponsors

lead

Collegium Medicum w Bydgoszczy

OTHER

NCT02612116 - Comparison of Administration Strategies of Ticagrelor in Patients With Unstable Angina Pectoris, a Pharmacokinetic / Pharmacodynamic Study | Biotech Hunter | Biotech Hunter